Teva Board Members Take 50% Pay Cut Post author:Sam Post published:January 10, 2018 Post category:BioPharma Teva has made a target of cutting costs by $3B by the end of 2019. Source: BioSpace You Might Also Like Little Idorsia Scores $230M+ R&D Deal With Johnson & Johnson December 3, 2017 Sangamo, Pfizer Deepen Relationship With New $162M ALS R&D Pact January 2, 2018 Boehringer Ingelheim, Roche Forge Partnership for Inflammatory Bowel Diseases December 18, 2017
